Literature DB >> 9413288

Variability in anticoagulation control predicts thromboembolism after mechanical cardiac valve replacement: a 23-year population-based study.

K C Huber1, B J Gersh, K R Bailey, H V Schaff, D O Hodge, R H Cha, J H Chesebro.   

Abstract

OBJECTIVE: To assess optimal control of blood anticoagulation to maximize antithrombotic protection after mechanical cardiac valve replacement.
DESIGN: A population-based study of 96 patients with a mean follow-up of 7.7 years (range, 1 month to 23 years) was performed in Olmsted County, Minnesota, and 10,301 prothrombin time (PT) ratios were determined after mechanical heart valve replacement.
MATERIAL AND METHODS: PT ratios were analyzed in a new time-dependent Cox proportional-hazards model by defining an algorithm for comparing variability in PT ratios at each month of follow-up and relating these to thromboembolic events. The new method was compared with several conventional time-independent definitions.
RESULTS: During 740 person-years of follow-up, 19 of 96 patients (20%) had 27 thromboembolic events. Of these 19 patients, 8 (42%) had events within 3 months after valve replacement. Freedom from any thromboembolic event was 72% at 15 years. The event rate was high (7.5% per year) during high variability and low (0.9% per year) during low variability in the PT ratio. This relationship was lost when time dependence was removed. More PT ratios were less than 1.5 during high (27%) than during low (19%) variability. Several conventional definitions of adequacy of anticoagulation that averaged PT ratios before a thromboembolic event or throughout follow-up or that compared the proportion of PT ratios above or below a fixed ratio did not define or only partially defined different thromboembolic risks.
CONCLUSION: Periods of high and low variability of PT ratios define high and low risk of thromboembolism, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413288     DOI: 10.4065/72.12.1103

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

Review 1.  Antithrombotic therapy for prosthetic valves: routine treatment and special considerations.

Authors:  A M Al-Ahmad; D Hartnett-Daudelin; D N Salem
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

2.  Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.

Authors:  Sean D Pokorney; DaJuanicia N Holmes; Laine Thomas; Gregg C Fonarow; Peter R Kowey; James A Reiffel; Daniel E Singer; James V Freeman; Bernard J Gersh; Kenneth W Mahaffey; Elaine M Hylek; Gerald V Naccarelli; Michael D Ezekowitz; Jonathan P Piccini; Eric D Peterson
Journal:  JAMA Cardiol       Date:  2019-08-01       Impact factor: 14.676

3.  Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario.

Authors:  Devendra Saksena; Yugal K Mishra; S Muralidharan; Vivek Kanhere; Pankaj Srivastava; C P Srivastava
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.